RevOpsis Therapeutics

About RevOpsis Therapeutics

RevOpsis is dedicated to revolutionizing multi-specific antibody discovery and development, with a focus on solving blindness through rapid discovery and development of novel therapies using their proprietary RevMod Platform. Their therapeutic candidates target dominant biologic pathways in complex multifactorial diseases to achieve improved outcomes and extended remission.

Products & Services

Lead Product (TriMod Biologic):A first-in-class TriMod biologic designed to treat retinal vascular disease.

RevMod Platform:A plug-and-play system for developing multispecific biologics.

Future Innovation (MultiMod Biologics):A system with full compatibility for efficient design of MultiMod biologics.

Specialties

Multi-specific antibody discovery Multi-specific biologics development Retinal vascular disease treatment Therapeutic innovation for blindness

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Grant T: - FT: SBIR Grant	A: 1800000 MR: - FA: $1.8 million FAN: 1800000	D: 2024-10-15 FD: 2024-10-15	1 investors
2	RT: Seed T: - FT: Seed	A: 16500000 MR: - FA: 16.5 million FAN: 16500000	D: 2024-04-25 FD: 2024-04-25	5 investors

SBIR Grant Latest

2024-10-15

$1.8M

1 investor (Pro only)

Seed 2024-04-25

$16.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ramanath Bhandari

Co-founder, CEO, & Board Chairman

R

Ramesh Bhatt

Chief Scientific Officer

R

Ronil Patel

Chief Business Officer

L

Li Xu

Vice President of Discovery

J

Jeff Olson

Co-founder & Board of Directors

R

Ram Palanki

Board of Directors

View 11 more team members with Pro

Unlock Full Team Directory

Recent News